The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aerovate Therapeutics, Inc. | Common Stock | 008064107 | 34,973,120 | 2,039,249 | SH | SOLE | 2,039,249 | 0 | 0 | |||
Akero Therapeutics, Inc. | Common Stock | 00973Y108 | 27,745,579 | 594,251 | SH | SOLE | 594,251 | 0 | 0 | |||
AvroBio, Inc. | Common Stock | 05455M100 | 4,314,766 | 4,541,381 | SH | SOLE | 4,541,381 | 0 | 0 | |||
Day One Biopharmaceuticals, Inc. | Common Stock | 23954D109 | 90,844,224 | 7,608,394 | SH | SOLE | 7,608,394 | 0 | 0 | |||
Disc Medicine, Inc. | Common Stock | 254604101 | 153,703,210 | 3,461,784 | SH | SOLE | 3,461,784 | 0 | 0 | |||
Dyne Therapeutics, Inc. | Common Stock | 26818M108 | 111,211,301 | 9,885,449 | SH | SOLE | 9,885,449 | 0 | 0 | |||
Generation Bio, Co. | Common Stock | 37148K100 | 45,537,162 | 8,279,484 | SH | SOLE | 8,279,484 | 0 | 0 | |||
Ikena Oncology, Inc. | Common Stock | 45175G108 | 32,919,248 | 5,018,178 | SH | SOLE | 5,018,178 | 0 | 0 | |||
Kymera Therapeutics, Inc. | Common Stock | 501575104 | 134,681,443 | 5,858,262 | SH | SOLE | 5,858,262 | 0 | 0 | |||
Magenta Therapeutics, Inc. | Common Stock | 55910K108 | 2,874,107 | 3,791,698 | SH | SOLE | 3,791,698 | 0 | 0 | |||
Replimune Group, Inc. | Common Stock | 76029N106 | 48,722,526 | 2,098,300 | SH | SOLE | 2,098,300 | 0 | 0 | |||
Spero Therapeutics, Inc. | Common Stock | 84833T103 | 1,469,485 | 1,013,438 | SH | SOLE | 1,013,438 | 0 | 0 | |||
Third Harmonic Bio, Inc. | Common Stock | 88427A107 | 52,466,802 | 10,907,859 | SH | SOLE | 10,907,859 | 0 | 0 | |||
Vigil Neuroscience, Inc. | Common Stock | 92673K108 | 54,866,616 | 5,836,874 | SH | SOLE | 5,836,874 | 0 | 0 | |||
Xilio Therapeutics, Inc. | Common Stock | 98422T100 | 7,229,481 | 2,759,344 | SH | SOLE | 2,759,344 | 0 | 0 |